2002
Lidocaine Patch for Pain of Erythromelalgia
Search citation statements
Paper Sections
Select...
34
10
1
0
Citation Types
0
31
1
0
Year Published
2000
2026
Publication Types
Select...
40
3
1
Relationship
3
41
Authors
Journals
Cited by 44 publications
(32 citation statements)
References 10 publications
0
31
1
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Similarly, in a study involving 34 patients with EM who were treated at a specialized facility, most of those who applied lidocaine 5% patches reported reduced pain. This was in contrast to a group of 10 patients who did not experience any relief when using lidocaine gel [ 33 ]. Michelerio et al [ 22 ] emphasized the differing levels of effectiveness among various treatments, identifying antihistamines, venlafaxine, and mexiletine as the most promising options.…”
Section: Discussion
contrasting
confidence: 61%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Similarly, in a study involving 34 patients with EM who were treated at a specialized facility, most of those who applied lidocaine 5% patches reported reduced pain. This was in contrast to a group of 10 patients who did not experience any relief when using lidocaine gel [ 33 ]. Michelerio et al [ 22 ] emphasized the differing levels of effectiveness among various treatments, identifying antihistamines, venlafaxine, and mexiletine as the most promising options.…”
Section: Discussion
contrasting
confidence: 61%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…8 This observation is supported by a follow-up case series study, which showed that the lidocaine patch improved symptoms in 18 out of 34 erythromelalgia patients. 6 Lidocaine patches can also be effectively utilized in pediatric patients. In a review of 32 pediatric erythromelalgia cases, lidocaine was the most commonly prescribed treatment (44%).…”
Section: T a B L E 1 Topical Therapies For Erythromelalgia
mentioning
confidence: 71%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Topical agents may be used to avoid systemic adverse effects. Preparations containing amitriptyline-ketamine, lidocaine, midodrine (α1-agonist), NSAIDs, and gabapentin have been described, with variable success in symptom control [ 32 , 33 ]. Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide), derived from chili peppers and commonly used for diabetic and postherpetic neuropathy, has shown success in alleviating pain in erythromelalgia in several case reports [ 34 , 35 ].…”
Section: Discussion
mentioning
confidence: 99%
